Pharmacogenomics of Antiplatelet Response
NCT02234427
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Atherosclerosis
Interventions
DRUG:
Aspirin
Sponsor
Johns Hopkins University